In VivoFrom potential use as gene therapy delivery vehicles to anti-inflammatory therapies and cancer drugs, there has been excitement around exosomes since these stem cell components were first observed in
In VivoThermo Fisher Scientific was one of the first companies in its peer group to have its near and long-term net-zero targets validated by the Science Based Targets initiative (SBTi). The company aims to
ScripGalapagos is to launch its first US-based clinical trial of its point-of-care CAR-T technology, which it hopes can be a game-changer in oncology. The novel CAR-T technology has been Galapagos’s brigh
ScripFlagship Pioneering is adding to the list of large pharma partners for its portfolio of start-up companies, this time with a deal with GSK plc . The Cambridge, MA-based venture capital firm and the L